Twist Bioscience Corp at UBS Global Healthcare Conference Transcript
Great. So we're hosting Twist Biosciences for our next fireside chat. I have with me Jim Thorburn, CFO; and Angela Bitting, SVP of Corporate Affairs. Fireside chat format. If anyone in the audience has any questions, feel free to use the app, and we can bring them up here on the iPad. But with that, I'll go ahead and get started.
Questions & Answers
So Jim, Twist's portfolio touches on several fast-growing areas like Discovery, NGS, SynBio. Where do you see the largest growth drivers over the near term and maybe over the long term?
Yes. It's an interesting question. I mean, over the last few years, we've been growing at roughly twice the market. The overall market is about $3 billion. If you just look at our last quarter numbers, we're up roughly 50% year-over-year. So if you look at the 2 key elements of the portfolio, NGS and SynBio, this year, we're projecting NGS to be about $94 million to $96 million. Looking at SynBio,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
